November 2015

TGA Issues Safety Warning on Andrographis

The Therapeutic Goods Administration (TGA) in Australia recently issued a safety advisory warning consumers about the risk of allergic reactions from Andrographis paniculata, a plant commonly used in dietary supplements for the prevention of the cold and flu. The TGA warned that between December 2002 and April 2014, the TGA received 43 reports of anaphylaxis and 78 reports of other allergic reactions from people who took products containing Andrographis. The TGA noted that while Andrographis is usually safe, some people might have severe allergic reactions and consumers should seek immediate medical attention if any symptoms arise.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.